Nektar Therapeutics
Open
79 -3.49
Overview
Share price change
24h
Min
78.75
Max
81.79
Income | -557K -36M |
|---|---|
Sales | 10M 22M |
EPS | -1.29 |
Profit margin | -165.447 |
Employees | 63 |
EBITDA | 10M -19M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +87.7% upside |
Next Earnings | 6 Aug 2026 |
|---|
Market Cap | 997M 2.9B |
|---|---|
Previous open | 82.49 |
Previous close | 79 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Nektar Therapeutics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
87.7% upside
12 Months Forecast
Average 153.71 USD 87.7%
High 192 USD
Low 80 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$